Studies On Wf-3681, A Novel Aldose Reductase Inhibitor I. Taxonomy, Fermentation, Isolation And Characterization

The Journal of Antibiotics

Volumn 40, Issue 10, 1987, Pages 1394-1399

  Nishikawa, Motoaki ^a   Tsurumi, Yasuhisa ^a   Namiki, Takayuki ^a   Yoshida, Keizo ^a   Okuhara, Masakuni ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

3 (2,5 DIHYDRO 4 HYDROXY 5 OXO 3 PHENYL 2 FURYL)PROPIONIC ACID; ALDEHYDE REDUCTASE; NEW DRUG;

ANIMAL CELL; DRUG ISOLATION; DRUG SCREENING; DRUG STRUCTURE; ENZYME INHIBITION; FUNGUS; IN VITRO STUDY; INFRARED SPECTROPHOTOMETRY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; VISUAL SYSTEM;

ALDEHYDE REDUCTASE; ANIMAL; CHEMISTRY; ENZYME INHIBITORS; FERMENTATION; FURANS; MITOSPORIC FUNGI; RABBITS; SUGAR ALCOHOL DEHYDROGENASES;

EID: 0023280891     PISSN: 00218820     EISSN: 18811469     Source Type: Journal    
DOI: 10.7164/antibiotics.40.1394     Document Type: Article

References (11)

1. Kinoshita, J. H.: Mechanism initiating cataract formation. Proctor Lecture Invest. Ophthalmol. 13: 713–724, 1974
2. Gabbay, K. H.: The sorbitol pathway and the complications of diabetes. N. Engl. J. Med. 288: 831 — 836, 1973
3. Kuwabara, T. & D. G. Cogan : Retinal vascular patterns VI. Mural cells of the retinal capillaries. Arch. Ophthalmol. 69: 492–502, 1963
4. Akagi, Y.; P. F. Kador, T. Kuwabara & J. H. Kinoshita: Aldose reductase in human retinal mural cells. Invest. Ophthalmol. Visual Sci. 24: 1516—1519, 1983
5. Corder, C. N.; J. H. Braughler & P. A. Culp: Quantitative histochemistry of the sorbitol pathway in glomeruli and small arteries of human diabetic kidney. Folia Histochem. Cytochem. 17: 137—146, 1979
6. Hayman, S. & J. H. Kinoshita: Isolation and properties of lens aldose reductase. J. Biol. Chem. 240: 877–882, 1965
7. Namiki, T.; M. Nishikawa, Y. Itoh, I. Uchida & M. Hashimoto: Studies on WF-3681, a novel aldose reductase inhibitor. II. Structure determination and synthesis. J. Antibiotics 40: 1400—1407, 1987
8. Kador, P. F.; W. G. Robison & J. H. Kinoshita: The pharmacology of aldose reductase inhibitors. Annu. Rev. Pharmacol. Toxicol. 25: 691 — 714, 1985
9. Jaspan, J.; R. Maselli, K. Herold & C. Bartkus: Treatment of severely painful diabetic neuropathy with an aldose reductase inhibitor: Relief of pain and improved somatic and autonomic nerve function. Lancet 1983-11: 758–762, 1983
10. Judzewitsch, R. G.; J. B. Jaspan, K. S. Polonsky, C. R. Weinberg, J. B. Halter, E. Halar, M. A. Pfeifer, C. Vukadinovic, L. Bernstein, M. Schneider, K.-Y. Liang, K. H. Gabbay, A. H. Rubenstein & Daniel Porte, Jr.: Aldose reductase inhibition improves nerve conduction velocity in diabetic patients. N. Engl. J. Med. 308: 119–125, 1983
11. Goto, Y.; N. Oikawa, Y. Akanuma & M. Kikuchi: Clinical study on a new aldose reductase inhibitor (ONO-2235) in diabetic neuropathy. J. Jpn. Diabet. Soc. 28: 89 — 99, 1985